| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 149, 1675-1683, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
C Vingsbo, P Sahlstrand, JG Brun, R Jonsson, T Saxne and R Holmdahl
Department of Cell and Molecular Biology, Lund University, Sweden.
We present a novel animal model for rheumatoid arthritis induced with a well defined synthetic adjuvant oil, pristane. Two weeks after a single intradermal injection of 150 microliters of pristane, the rats developed severe and chronic arthritis. The inflammation was restricted to the joints and involved pannus formation, major histocompatibility complex (MHC) class II expression, and T lymphocyte infiltration. The initial development as well as the chronic stage of pristane-induced arthritis was ameliorated by treatment with antibodies to the alpha beta-T-cell receptor showing that the disease is T cell dependent. Increased levels of interleukin in serum was seen after pristane injection but not during the chronic stage of arthritis. Joint erosions were accompanied by elevated serum levels of cartilage oligomeric matrix protein. Comparison of MHC congenic LEW strains showed that the severity and chronicity of arthritis varied among the different MHC haplotypes. Rats with RT1f haplotype showed a significantly higher susceptibility to pristane-induced arthritis. A strong influence of non- MHC genes was also suggested by the variability of arthritis susceptibility among different strains with the same MHC haplotype; the most susceptible background was the DA and the least susceptible was the E3. Arthritis induced with a well defined nonimmunogenic adjuvant, with a disease course that closely resembles that of rheumatoid arthritis, makes a suitable animal model for future studies of the pathology and genetics of rheumatoid arthritis.
This article has been cited by other articles:
![]() |
M. H. Hoffmann, J. Tuncel, K. Skriner, M. Tohidast-Akrad, B. Turk, S. Pinol-Roma, G. Serre, G. Schett, J. S. Smolen, R. Holmdahl, et al. The Rheumatoid Arthritis-Associated Autoantigen hnRNP-A2 (RA33) Is a Major Stimulator of Autoimmunity in Rats with Pristane-Induced Arthritis J. Immunol., December 1, 2007; 179(11): 7568 - 7576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brenner, T. Laragione, A. Mello, and P. S Gulko Cia25 on rat chromosome 12 regulates severity of autoimmune arthritis induced with pristane and with collagen Ann Rheum Dis, July 1, 2007; 66(7): 952 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Joe Quest for arthritis-causative genetic factors in the rat Physiol Genomics, January 12, 2007; 27(1): 1 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Brenner, C Braun, M Oster, and P S Gulko Thermal signature analysis as a novel method for evaluating inflammatory arthritis activity Ann Rheum Dis, March 1, 2006; 65(3): 306 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Holmberg, J. Tuncel, H. Yamada, S. Lu, P. Olofsson, and R. Holmdahl Pristane, a Non-Antigenic Adjuvant, Induces MHC Class II-Restricted, Arthritogenic T Cells in the Rat J. Immunol., January 15, 2006; 176(2): 1172 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brenner, H.-C. Meng, N. C. Yarlett, B. Joe, M. M. Griffiths, E. F. Remmers, R. L. Wilder, and P. S. Gulko The Non-MHC Quantitative Trait Locus Cia5 Contains Three Major Arthritis Genes That Differentially Regulate Disease Severity, Pannus Formation, and Joint Damage in Collagen- and Pristane-Induced Arthritis J. Immunol., June 15, 2005; 174(12): 7894 - 7903. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Lange, E Bajtner, C Rintisch, K S Nandakumar, U Sack, and R Holmdahl Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis Ann Rheum Dis, April 1, 2005; 64(4): 599 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hultqvist, P. Olofsson, J. Holmberg, B. T. Backstrom, J. Tordsson, and R. Holmdahl Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene PNAS, August 24, 2004; 101(34): 12646 - 12651. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Olofsson, J. Holmberg, U. Pettersson, and R. Holmdahl Identification and Isolation of Dominant Susceptibility Loci for Pristane-Induced Arthritis J. Immunol., July 1, 2003; 171(1): 407 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Barton, S. Eyre, A. Myerscough, B. Brintnell, D. Ward, W.E.R. Ollier, J.C. Lorentzen, L. Klareskog, A. Silman, S. John, et al. High resolution linkage and association mapping identifies a novel rheumatoid arthritis susceptibility locus homologous to one linked to two rat models of inflammatory arthritis Hum. Mol. Genet., September 1, 2001; 10(18): 1901 - 1906. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Månsson, A Gülfe, P Geborek, D Heinegård, and T Saxne Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis Ann Rheum Dis, January 1, 2001; 60(1): 27 - 31. [Abstract] [Full Text] |
||||
![]() |
B. C. Carlson, A. M. Jansson, A. Larsson, A. Bucht, and J. C. Lorentzen The Endogenous Adjuvant Squalene Can Induce a Chronic T-Cell-Mediated Arthritis in Rats Am. J. Pathol., June 1, 2000; 156(6): 2057 - 2065. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. WILDER, M. M. GRIFFITHS, G. W. CANNON, R. CASPI, and E. F. REMMERS Susceptibility to Autoimmune Disease and Drug Addiction in Inbred Rats: Are There Mechanistic Factors in Common Related to Abnormalities in Hypothalamic-Pituitary-Adrenal Axis and Stress Response Function? Ann. N.Y. Acad. Sci., January 1, 2000; 917(1): 784 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Miagkov, D. V. Kovalenko, C. E. Brown, J. R. Didsbury, J. P. Cogswell, S. A. Stimpson, A. S. Baldwin, and S. S. Makarov NF-kappa B activation provides the potential link between inflammation and hyperplasia in the arthritic joint PNAS, November 10, 1998; 95(23): 13859 - 13864. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |